WCM Investment Management’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,236,059
| Closed | -$311M | – | 220 |
|
|
2022
Q3 | $311M | Buy |
1,236,059
+134,020
| +12% | +$33.7M | 1.11% | 28 |
|
|
2022
Q2 | $330M | Sell |
1,102,039
-424,442
| -28% | -$127M | 1.18% | 26 |
|
|
2022
Q1 | $627M | Buy |
1,526,481
+11,655
| +0.8% | +$4.79M | 1.75% | 15 |
|
|
2021
Q4 | $710M | Buy |
1,514,826
+72,006
| +5% | +$33.8M | 1.6% | 17 |
|
|
2021
Q3 | $613M | Sell |
1,442,820
-237,453
| -14% | -$101M | 1.42% | 18 |
|
|
2021
Q2 | $603M | Buy |
1,680,273
+7,599
| +0.5% | +$2.73M | 1.53% | 16 |
|
|
2021
Q1 | $471M | Buy |
1,672,674
+59,302
| +4% | +$16.7M | 1.29% | 15 |
|
|
2020
Q4 | $457M | Buy |
1,613,372
+240,412
| +18% | +$68.1M | 1.24% | 15 |
|
|
2020
Q3 | $377M | Sell |
1,372,960
-186,749
| -12% | -$51.3M | 1.32% | 14 |
|
|
2020
Q2 | $354M | Buy |
1,559,709
+148,890
| +11% | +$33.8M | 1.36% | 13 |
|
|
2020
Q1 | $215M | Buy |
1,410,819
+72,700
| +5% | +$11.1M | 1.19% | 18 |
|
|
2019
Q4 | $201M | Sell |
1,338,119
-15,376
| -1% | -$2.31M | 1.08% | 16 |
|
|
2019
Q3 | $192M | Buy |
1,353,495
+61,308
| +5% | +$8.69M | 1.15% | 14 |
|
|
2019
Q2 | $162M | Buy |
1,292,187
+170,071
| +15% | +$21.3M | 1.01% | 19 |
|
|
2019
Q1 | $124M | Buy |
1,122,116
+13,448
| +1% | +$1.48M | 0.86% | 24 |
|
|
2018
Q4 | $109M | Buy |
1,108,668
+72,634
| +7% | +$7.12M | 0.97% | 22 |
|
|
2018
Q3 | $128M | Buy |
1,036,034
+350,614
| +51% | +$43.3M | 1.15% | 16 |
|
|
2018
Q2 | $68.1M | Buy |
685,420
+117,433
| +21% | +$11.7M | 0.7% | 29 |
|
|
2018
Q1 | $50.1M | Buy |
+567,987
| New | +$50.1M | 0.47% | 31 |
|